Somatoform disorders in patients with musculoskeletal and cardiovascular diseases in comparison to the general population
- 1 August 2003
- journal article
- website
- Published by Cambridge University Press (CUP) in Acta Neuropsychiatrica
- Vol. 15 (4) , 192-198
- https://doi.org/10.1034/j.1601-5215.2003.00035.x
Abstract
Objective:: The present epidemiological study investigates sex- and age-adjusted 4-week, 12-month, and lifetime prevalence rates of somatoform disorders in in-patients with musculoskeletal and cardiovascular diseases in comparison with prevalence rates of these disorders in the general population in Germany.Methods:: Prevalence rates were calculated from two samples, one from rehabilitation in-patients with musculoskeletal (n = 187) or cardiovascular (n = 116) diseases, and one from a large sample of the German National Health Interview and Examination Survey – Mental Health Supplement (GHS-MHS; n = 3889). The prevalence rates were based on the M-CIDI, an interview for the assessment of mental disorders.Results:: The adjusted prevalence rates of any mental disorder in both clinical samples are higher compared with rates of the general population (e.g. lifetime musculoskeletal, 59.3%; cardiovascular, 56.2%; general population, 47.9%). Prevalence rates of patients with cardiovascular (e.g. 12.2%) and musculoskeletal (21.5%) diseases do not indicate an increased prevalence of somatoform disorders compared with the general population (18.2%).Conclusions:: The results confirm that patients with chronic somatic diseases have increased prevalence rates of mental disorders. However, these increased prevalence rates go primarily back to affective and anxiety disorders and not to somatoform disorders. The diagnostic criteria for somatoform disorders and the question algorithm of the M-CIDI are probably responsible for potential underestimation of somatoform disorders in patients with chronic somatic diseases.Keywords
This publication has 21 references indexed in Scilit:
- Identifying Somatization Disorder in a Population-Based Health Examination Survey: Psychosocial Burden and Gender DifferencesPsychosomatics, 2001
- Screening for mental disorders in cancer patients – discriminant validity of HADS and GHQ‐12 assessed by standardized clinical interviewInternational Journal of Methods in Psychiatric Research, 2001
- Prevalence, comorbidity, disability and service utilisationThe British Journal of Psychiatry, 2001
- Screening for anxiety, depressive and somatoform disorders in rehabilitation?validity of HADS and GHQ-12 in patients with musculoskeletal diseaseDisability and Rehabilitation, 2001
- The National Psychiatric Morbidity Surveys of Great Britain – initial findings from the Household SurveyPsychological Medicine, 1997
- The validity of two versions of the GHQ in the WHO study of mental illness in general health carePsychological Medicine, 1997
- Medically Unexplained Somatic Symptoms in Different CulturesPsychotherapy and Psychosomatics, 1995
- Chronic musculoskeletal pain and depressive symptoms in the national health and nutrition examination I. Epidemiologic follow-up studyPain, 1993
- Cross-cultural Feasibility, Reliability and Sources of Variance of the Composite International Diagnostic Interview (CIDI)The British Journal of Psychiatry, 1991
- Affective, substance use, and anxiety disorders in persons with arthritis, diabetes, heart disease, high blood pressure, or chronic lung conditionsGeneral Hospital Psychiatry, 1989